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1. Introduction 
Coronary artery disease is the leading cause of mortality in western countries. Myocardial 
contraction is indeed closely connected to coronary flow and oxygen delivery; the balance 
between oxygen supply and demand is a crucial determinant of the normal function of the 
heart. Acute impairment of this relationship due to coronary blood flow reduction results in 
a vicious cycle, where ischemia-induced contractile dysfunction causes hypotension and 
further myocardial ischemia.  
The presence of an atheromatous plaque modifies the normal pressure profile of the epicardial 
coronary vessels, obstructing its lumen and stimulating the circulation counter-measures to 
face it properly. An accurate knowledge of the coronary flow is essential to fully understand 
the nature and pathophysiological bases of many disorders. Systolic and diastolic variations in 
coronary blood flow are markers of myocardial oxygen demand due to the various flow 
control systems, such as mechanic, anatomic, hemodynamic. Microcirculation disorders affect 
the coronary flow controls too. The availability of high effective therapies able to prevent 
major cardiac events raised great interest in early diagnosis and widened the indications of 
Doppler Echocardiography in the evaluation of the ischemic cardiomyopathy. 
2. CFR: the invasive assessment 
The Coronary Flow Reserve (CFR) assessment via Trans-Thoracic Echo-color Doppler is 
nowadays a reality in clinical practice: it is a reliable, cheap, non-invasive and easy to 
perform test to assess the coronary flow at rest and after the administration of drugs. Other 
techniques, such as thermodiluition, Magnetic Resonance (MR), Positron Emission 
Tomography (PET) and intracoronary Doppler Flow Wire have limited indications, because 
they are time and money consuming and, of course, because they are invasive techniques1. 
PET is considered the gold standard among all invasive methods to estimate the CFR2. Newer 
techniques recently introduced in clinical practice are Thermodiluition, Fractional Flow 
Reserve and Doppler Flow Wire. 
Thermodilution is an indicator-dilution method of measuring blood flow. This method is 
based on the premise that when an indicator substance is added to circulating blood, the 
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rate of blood flow is inversely proportional to the change in concentration of the indicator 
over time. CFR assessment with the thermodiluition method requires a pressure wire 
introduced into a coronary vessel for at least 5-7 in. using a guiding catheter during a 
coronary catheterization. 70 I.U. of heparin intravenously and 100-200 mg of intracoronaric 
nitroglycerin have to be given before starting the procedure, to reduce vasoconstriction. The 
pressure sensor is located 1 in. far from the wire soft tip, being the distal sensor, while the 
proximal one is the wire shaft. A software program calculates all the gathered data to 
provide information about the mean transit time of a determined quantity of saline solution 
injected at ambient temperature. The baseline value is the mean of 3 consecutive injections 
of 3 ml of saline solution; the operator must repeat this procedure immediately after the 
administration of a pharmacological stressor, obtaining the hyperemic mean transit time. 
Hyperemic peak value is inducible with the intracoronaric administration of papaverine (12 
mg for the right coronary artery; 20 mg for the left coronary artery) or using a continuous 
administration of adenosine (140 mg/Kg/min). Being the vessel volume invariable, the 
mean transit time is inversely proportional to the flow: the mean hyperemic on the mean 
baseline time ratio provides the CFR estimation. This is a fast and cheap assessment, which 
can be performed with the simultaneous Fractional Flow Reserve (FFR) estimation using the 
Doppler technique without any additional hardware3. Its limits are in being invasive, in the 
mismatch with the CFR Doppler Flow Wire values (the variability range is 20%) and the 
usual over estimated values in distal coronary vessels. 
The FFR (FIG 1) is a technique used in coronary catheterization, allowing the pressure and the 
flow measurement in a defined coronary artery. Measuring the pressure differences across a 
stenosis means understanding if that stenosis impedes the oxygen delivery to the heart muscle. 
The FFR itself is the ratio between maximum post-stenotic flow and maximum pre-stenotic 
flow. The assessment is performed after coronary catheterization and during maximal blood 
flow, using a pressure flow wire pulled back as the pressures are detected by the sensors on it. 
The CFR values obtained are well related with PET data4. The obtained values are considered 
normal if above 0.80 (FIG 2). The combined use of FFR and thermodiluition give answers on 
the state of myocardial microcirculation in patients with diffuse vessel injuries5. 
 
Fig. 1.  
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Fig. 2.  
The Doppler Flow Wire (FIG 3) allows an invasive measurement of CFR and coronary flow 
speed at rest and during maximal blood flow. The Flow Wire is a floppy and flexible tipped 
wire, whose top carries a Doppler transducer to assess peak and mean flow speed within the 
vessels. Flow and flow speed are directly proportional, so it is possible to obtain a CFR 
estimation using the flow ratio. Doppler Flow Wire (DFW) and CFR are well related with 
other, already diffused techniques6. 
 
Fig. 3.  
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3. Echocardiography and CFR: from trans-esophageal to trans-thoracic 
approach 
Non invasive techniques are attractive methods to quantify pathophysiology. 
The assessment of coronary flow reserve with trans-thoracic doppler echocardiography 
(FIG 4), measured as the ratio between hyperaemic and baseline coronary flow velocities, is 
a new tool for coronary artery disease and coronary microcirculation evaluation.   
 
Fig. 4.  
For the proximity of the heart to the thoracic wall and the wide spaces between the ribs, 
echocardiography always provided lots of useful information about cardiac morphology and 
functionality. The Trans-Esophageal Echocardiography (TEE) uses an even closer point of 
view on the heart (FIG 5) and then it expanded the diagnostic capabilities of 
echocardiography. This happened thanks to multi-planar, high frequency (7 MHz) 
transducers, capable of color Doppler and Pulsed Wave Doppler visualization of the coronary 
flow. The superior resolution and the lack of anatomical obstacles are the best advantages of 
this technique7: TEE allows the visualization of the ascending aorta and the first segments of 
the coronary arteries. There are Authors who documented the stenosis of the proximal part of 
the common trunk using TEE8. Anterior descending artery is almost parallel to the ultrasound 
beam, thus being ideal for a Doppler assessment: resting flow speeds are normal before to a 
stenosis, faster within the stenosis and significantly slower after it7. The most important 
information are provided by the TEE-CFR assessment with the intravenous administration of 
adenosine or dipyridamole9. This kind of evaluation is very easy to perform and its prognostic 
value, concerning the proximal segment of the anterior descending artery, is very high10, 
allowing the common trunk cross-sectional area and the coronary flow measurement11 (FIG 6). 
The clinical usefulness of TEE-CFR is limited by an important factor: the difficulty, for the 
patient, to undergo such an invasive assessment. The evaluation of CFR in cases of distal 
coronary stenoses still remains impossible and this is another important limitation. 
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Fig. 5. 
 
Fig. 6.  
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Trans Thoracic Echocardiography (TTE), especially after the introduction of Tissue 
Harmonic Imaging (THI), made possible the evaluation of the coronary flow via pulsed-
wave Doppler, color Doppler guided12. Anterior descending artery, in its intermediate and 
terminal parts is ideal for this kind of assessment: it is very close to the thoracic wall, while 
the circumflex branch of left coronary and posterior descending artery are less reachable by 
the ultrasonic beam (FIG 7). The frames are acquired through an apical 2-chambers 
modified echocardiographic view, using the color-Doppler guidance to optimize the 
targeting of the vessel with the probe. The Doppler signal itself can be enhanced, if 
necessary, giving a contrast agent (e.g.: SonoVue, Levovist). In this specific projection a 
craniad tilting of the probe is requested: at first the operator must target the anterior 
interventricular groove, looking for the anterior descending artery, with the color-Doppler 
function active. Then, rotating the transducer counterclockwise and tilting it craniad, the 
requested point of view should be reached. All this procedure is ECG-gated (FIG 8), being 
the images much sharper during the diastole; moreover, it is noticeable that the coronary 
blood flow is continuous and its diastolic part is wider than the systolic. The diastolic 
coronary flow speeds usually span the range 15 to 30 cm/sec. It's crucial to identify the 
internal mammary artery, which, for its close proximity to the anterior descending one, can 
be a confounding factor for the assessment: this is easily possible because for that artery 
there are no heartbeat movements and the systolic part of the flow is wider than the 
diastolic (FIG 9). TTE-CFR assessment is made possible by a main factor: the easy sampling 
of anterior descending artery, both in resting and hyperemic conditions (FIG 10). Each 
cardiac ultrasound unit is equipped with the right hardware to perform this kind of 
analysis, however, the operators must take care of some parameters: using low color 
Doppler rates (PRF 11-25 cm/sec); keeping a constant Doppler angle between the probe and  
 
Fig. 7.  
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Fig. 8. 
 
Fig. 9.  
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Fig. 10. 
the observed flow for the duration of the exam in order to compare the baseline and the 
hyperemic Doppler patterns; using a pulsed-wave Doppler volume dimension wider than 2 
mm, in order to overcome the sampling problems due to hyperventilation. TTE-CFR 
assessment feasibility is up to 98% and it is highly repeatable: for these reasons Doppler 
signal enhancement and contrast agents as well are not necessary. All collected data are 
strictly congruent with DFW. Using an apical, 2-chambers echocardiographic view is also 
possible to check the posterior interventricular artery: the feasibility of this examination is 
clearly worse, in this case, due to the over breathing induced by adenosine and for the use of 
common transducers (while for the anterior descending artery is already mandatory the use 
of dedicated probes). The overall feasibility of the TTE-CFR assessment is quite good in all 
the main epicardial coronary arteries: 98% for the anterior descending artery; 81% for the 
posterior interventricular one; 73% for the circumflex13. 
TTE-CFR assessment limitations: TTE-CFR has limited spatial resolution, making it 
impossible to evaluate the vessel cross-sectional area. According to some Authors'14 opinion, 
a CFR estimation is not fully reliable, if only based on flow speed data collection, but the 
reality is that adenosine-induced diameter variation of epicardial coronary arteries is always 
less than 5%, which means there is no statistical significance in such values15. Like in each 
Doppler analysis, CFR assessment is angle-dependant and it's important that this angle 
should be >30°, to avoid an underestimation of the factors, and it must be kept constant 
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before and after the hyperemic stimulation. The production of sampling artifacts is possible 
too: when a big marginal artery is mistaken for the anterior descending one; when the 
anterior descending artery is affected by a very distal stenosis, causing a CFR assessment 
which is exclusively based on a pre-stenotic data acquisition.  
4. Stressors used in CFR assessment 
There are various stressors used to induce myocardial ischemia and they all act these ways: 
the steal effect and the increased myocardial oxygen demand. The most commonly used 
stressors are drugs and non-pharmacologic stressors. 
Non pharmacological stressors are: exercise, which is the most commonly used, and pacing. 
Exercise test echocardiography is the closest to every day conditions: coronary flow 
increases as the double product of heart rate and systolic blood pressure (HR x SBP), which 
is used as an estimate of myocardial work and is proportional to myocardial oxygen 
consumption.  
The steal effect is caused by dipyridamole, while the increased myocardial oxygen demand 
is caused by the administration of dobutamine, by the pacing16 and by transient coronary 
obstruction17. 
Drugs used to induce coronary vasodilation are: dipyridamole, adenosine and papaverine, 
being this last one, the least commonly used. Dipyridamole reduces myocardial oxygen 
demand acting on the A2 adrenergic receptors placed on the smooth muscle cells and on the 
endothelial cells: it causes a bad blood flow distribution, thus a "steal effect". The fact is that 
it also indirectly raises the adenosine concentration, limiting its re-uptake and 
consumption18. Dipyridamole must be given in an intravenous administration of 0.84 
mg/Kg: in the traditional protocol19 this happens in 10 minutes, divided in 2 infusions (0.56 
mg/Kg over 4 minutes; 4 minutes of no dose and, if still negative, an additional 0.28 mg/Kg 
over 2 minutes) and eventually followed by the delivery of up to 1 mg of atropine in order 
to maximize the accuracy of the test. The sensitivity of the test increases using the fast 
protocol, that consists in the administration of a one-shot dose of 0.84 mg/Kg of 
dipyridamole in 6 minutes20 (FIG 11). This is useful to limit the duration of the test too. Wall 
Motion Score Index (WMSI) and anterior descending artery coronary flow are further 
parameters evaluable during CFR assessment with the fast protocol. Dipyridamole effects 
are quite long-lasting: up to 30 minutes and the peak effect can last up to 6-16. For this 
reason the main side effects of its use are hypotension, headache, nausea, flushing, then a 
fast administration of the right antidote, aminophylline21, should be considered. 
Contraindications to dipyridamole use are: third degree atrio-ventricular block, sick sinus 
syndrome, asthma. No more adenosine must be administered in the 24 hours following a 
CFR assessment, for its long lasting blood concentration; during the 24 hours before the 
examination the patient must avoid the use of coffee or tea-based drinks in order to test the 
largest number of free adenosine receptors. 
Adenosine acts through specific A2 inhibitor receptors located on the surface of smooth 
muscle cells and on the endothelium of epicardial coronary vessels. Its ischemia-inducing 
action is similar to dipyridamole, but for the direct and short-lasting effects (only a few 
seconds)22. Even side effects are the same, but really brief, in these cases and no aminophylline  
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Fig. 11. 
is usually required. In normal patients adenosine administration raises up to  4-5 times the 
coronary flow, just like high-dose dipyridamole23, however always much more than after 
dobutamine or after stress exercise. Dipyridamole can be manually injected using a syringe, 
but for adenosine an infusion pump is necessary and the starting dose is 100 µg/Kg/min, 
slowing raising up to 200 µg/Kg/min. The final administration of atropine at the end of the 
test to reach the maximal heart rate, raises its sensitivity in these cases too. To evaluate the 
CFR via TTE a dose of 140 µg/Kg/min in an endovenous infusion of 5 minutes is ideal24: 
imaging is performed prior and after the starting of the injection. Even better, because 
significantly cheaper, is the IV injection of only 6 mg of drug in 10-15 seconds (FIG 12). 
Adenosine test is always safe and reliable for the assessment of anterior descending artery 
stenoses25. 
Dobutamine is a sympathomimetic drug, directly acting on the ┚1 adrenergic myocardial 
receptors increasing heart rate and contractility and also acting on the ┚2 receptors on the 
epicardial coronary vessels, as a vasodilator26. Chronotropic and inotropic response to the 
dobutamine stimulation raises myocardial oxygen consumption, inducing ischemia: 
coronary flow increases 3 times the baseline value to face this condition. The drug is 
administered intravenously in incremental doses spanning the range 5 to 40 µg/Kg/min in 
repeated stages, each one lasting 3 minutes. If the maximal heart rate is not reached is 
possible a final administration of atropine. The feasibility of these tests is about 90%27, being 
also possible a WMSI and a anterior descending artery flow assessment. 
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Fig. 12. 
The most commonly used non-pharmacologic stressors are physical exercise, cardiac pacing 
and the Cold Pressure Test (CPT). 
Exercise echocardiography can be performed using either a treadmill or a bicycle protocol: 
when using a treadmill, scanning during exercise is not feasible, so it's mandatory an 
immediate post-exercise imaging as soon as possible (<1 minute from cessation of exercise). 
Bicycle exercise is performed during either an upright or a recumbent posture: in every 
moment during the various levels of exercise the collection of data is possible. Physical 
exercise acts raising the heart rate, the blood pressure values and the inotropic state, then 
raising the myocardial oxygen consumption as well: as a consequence, the CFR values raise 
too, because the coronary flow is controlled by the oxygen demand. The stress CFR is easier 
to assess using nuclear medicine techniques, such as Single-Photon Emission Computed 
Tomography (SPECT) or PET, than using ultrasound due to hyperventilation and chest wall 
movements. 
Cardiac pacing allows the induction of a controlled myocardial stress raising the heart rate, 
which is the main determinant of the oxygen demand. This result can be achieved via right 
atrium direct pacing during a catheterization procedure, via transesophageal atrial pacing or 
via atrial or ventricular noninvasive pacing exploiting the presence of a permanent pacemaker. 
External cardiac pacing requires the use of the standard echo-stress protocol: starting from 110 
beats per minute, the heart rate should be increased by 10 beats every 3 minutes until the 
target heart rate is reached (85% of age-predicted maximal heart rate). The same goals can be 
achieved in an accelerated fashion, increasing the heart rate every 30 seconds16. A limiting 
factor is that several pacemakers cannot be programmed to reach the target heart rate. 
Echocardiographic image acquisition is performed at baseline conditions and throughout the 
test; the final data collection is made after 3 minutes of pacing at the highest heart rate or at the 
target heart rate. The diagnostic accuracy of this stress test is remarkable. 
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The CPT is based on an endothelial dependant response to a thermal stimulation. The exam 
is performed putting a patient's hand in the cold water for 2-3 minutes, inducing a reactive 
hyperemia. This vasodilator response is caused by endothelial NO release, due to an a frigore 
sympathetic nervous system activation. With the subsequent reduced NO bioavailability, ┙-
adrenergic effects are no longer balanced and the ischemia prevails. The CPT assessed 
endothelial dysfunction is a good predictor of major cardiac events and is useful in 
prognostic stratification28. Nowadays normal reference ranges for CFR assessed via CPT still 
don't exist, so this test cannot be used to diagnose inducible ischemia yet29. 
5. Coronary Flow Reserve and epicardial coronary stenoses 
Estimating the patients' coronary reserve allows to estimate the rate at which this reserve 
may disappear: as a direct consequence it become possible to pronounce a correct prognosis 
and to give a proper therapy, directed to increase this reserve, preventing or eliminating the 
stresses that might compromise it. Downstream to an epicardial coronary stenosis there is a 
pressure drop directly proportional to the obstruction itself. If the stenosis is little or 
moderate, the blood flow is maintained by the vasodilation activated as a reaction. For an 
hemodynamically significant stenosis, angina symptoms start to appear. Over 70% of 
stenosis the coronary flow reserve cannot increase over the factor of 2x, defined as the 
normality cutoff. 85-90% stenoses can reduce the coronary blood flow even at rest, because 
the adaptive capabilities of coronary flow are completely lost: this is why CFR assessment is 
important in order to identify the least important obstructions, being an estimation of the 
functionality of compensatory mechanisms (FIG 13). The CFR dissolves for >90% 
obstructions. These data are true for isolated stenoses of a single vessel, without the 
involvement of microcirculation, nor side branches (FIG 14). Many more confounding 
factors may arise: the main one is certainly the microcirculatory dysfunction. TTE-CFR can 
be used in clinical practice to collect data comparable with that from invasive tests30. CFR 
normality cutoff is >2. This technique samples the blood flow typically from the anterior  
 
Fig. 13. 
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Fig. 14. 
descending artery, neglecting microcirculatory conditions: for this reason it should be 
integrated in a classic pharmacologic echocardiographic stress test to evaluate the regional 
wall motion. Both tests can be conducted using the same pharmacological stressor: 
dipyridamole. The combined Wall motion and CFR assessment, then, adds more sensitivity 
without a significant loss of specificity to the echocardiographic stress examination (FIG 15).  
Dipyridamole is a stressor drug particularly suitable for this use. A skilled operator can 
exploit another chance, assessing not only the anterior descending, but also the posterior 
descending and the circumflex arteries31. Performing the TTE-CFR assessment requires a 
skilled operator because of hyperventilation too: from 5 to 10 seconds after the 
administration of the pharmacological stressor the maximal hyperemia is observable and a 
significant hyperventilation occurs, making difficult to focus the ultrasonic beam on the 
assessed coronary artery. After all, without hyperventilation the test is not acceptable and 
the risk of an underestimation of CFR becomes very high (maybe because of the inadequate 
dose of drug or for a peculiar pool of cardiac receptors in the evaluated patient). 
Angiography may be unable to determine intermediate (40-70%) stenoses, revealing the 
need for a revascularization: a functional evaluation of the stenoses appears then crucial. 
Only the functionally significant stenoses, which are related to scintigraphically observable 
regional myocardial perfusion defects should be addressed to revascularization32. Moreover, 
CFR, if between 1.8 and 2.0, have a positive predictive value of 88-100% and a negative 
predictive value of 77-95% when there is a scintigraphically evident myocardial perfusion 
defect (FIG 16). CFR, then, recovers very early, even in the next few hours after the 
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Fig. 15. 
 
Fig. 16. 
procedure if all epicardial coronary stenoses are treated. TTE-CFR is also useful to evaluate the 
outcomes of revascularization procedures after acute events: it’s very important during the 
follow-up of a stenting procedure to assess the eventual in-stent restenosis with a sensitivity of 
78% and a specificity of 93% for each restenosis33 (FIG 17). It should be remembered that post 
surgical procedures a flow competition from the native coronary artery can reduce the blood 
stream even without a bypass stenosis. In these cases the best choice is to perform the TTE-
CFR directly on the native anterior descending artery34 (FIG 18)(FIG 19).  
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www.intechopen.com
Coronary Artery Disease 
 – Current Concepts in Epidemiology, Pathophysiology, Diagnostics and Treatment 58
 
Fig. 19. 
6. Coronary Flow Reserve and microcirculatory dysfunctions 
High intraventricular pressure, determining compression on microcirculation, generates a 
CFR much greater in subepicardial layer, than in subendocardial. CFR, then, dissolves first 
in subendocardial layer, when problems occur35 (FIG 20). Whether an epicardial coronary 
stenosis is present or not, CFR reduction can be caused by any condition producing 
microcirculation impairment: for intrinsic (inflammations,, endothelial damages, etc.) or 
extrinsic reasons (extra-vascular compression). There are 3 main types of microvascular 
dysfunctions (MD): 
- MD with epicardial coronary obstruction: atheromatous lesions are often related to 
microcirculation flow regulation impairment. 
- Inadequate revascularization: after surgical or percutaneous revascularization procedures, 
tissue edema and increased blood levels of free radicals can greatly damage 
microcirculation functionality. 
- No angiographically significant lesions: these are the cases of cardiac syndrome X 
(microvascular angina) or conditions related to several risk factors causing 
microvascular functionality damages, such as hypertension or diabetes mellitus. 
A reduced TTE-CFR means microcirculation impairment only if the coronary angiography 
does not show any epicardial stenosis. Performing a TTE-CFR assessment combined with an 
echocardiographic stress test for the coronary flow estimation in the anterior descending 
artery and the regional wall motion study is possible to overcome such limitations. The 
resulting scenarios are29: 
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a. Normal TTE-CFR + Normal wall motion = no damage. 
b. Reduced TTE-CFR + Impaired wall motion = epicardial coronary stenosis 
c. Reduced TTE-CFR + Normal or increased wall motion = coronary microcirculation 
isolated  dysfunction. 
d. Normal TTE-CFR + impaired wall motion in locations far from the observed artery  
In this last possibility, it's mandatory to perform TTE-CFR on right and circumflex 
coronary arteries too or to base any further decision only on the analysis of regional wall 
motion.  
Microvascular dysfunction without angiographically assessed epicardial coronary stenoses 
knows various causes, such as hypertensive cardiomyopathy, diabetes mellitus, 
hypertrophic cardiomyopathy, idiopathic dilated cardiomyopathy, cardiac syndrome X. 
TTE-CFR reduction, in these conditions, is highly variable, but it may become wider than 
observed as an exclusive consequence of anterior descending artery stenoses36. 
Hypertensive cardiomyopathy is nowadays the most assessed in all these conditions, using 
TTE-CFR; many studies showed that coronary reserve is reduced even without a clear left 
ventricle hypertrophy: probably this happens because of microcirculatory remodeling37. 
Functional  and morphological microcirculatory modifications are strictly joined and bioptic 
myocardial samples confirm this linkage. Endothelial dysfunction and extra-vascular 
compression are further possible causes. Concerning diabetes mellitus, especially for type 2, 
CFR reduction is insulin resistance38 related, while hyperglycaemic concentrations play a 
background role. Microangiopathy in diabetes knows the same progression, both in 
coronary microcirculation and in retina39. CFR can be reduced in dilated cardiomyopathy, 
mostly for the ventricular shear stress, which characterises this condition40. Cardiac 
syndrome X may reduce CFR just like observable in epicardial coronary stenoses41: stress 
tests induce angina pectoris, ST segment depression and scintigraphically relevant 
myocardial perfusion defects. TTE-CFR test effectiveness and wall motion analysis 
(echographic stress test using the fast protocol of dipyridamole injection) are maximized if 
also a coronarographic assessment is performed as a cross-check for the presence of 
epicardial coronary stenoses. After a revascularization procedure, microcirculatory 
conditions are crucially important: many studies showed that microvascular damage after 
acute myocardial infarction reaches its peak 48 hours after reperfusion42. Then, performing a 
CFR assessment after that peak time, provides important information on the 
microcirculatory damage and is a predictor of left ventricle functional recovery. In 
Myocardial Contrast Echocardiography (MCE) the non-reflow extent, which is greater in 
patients with a reduced TTE-CFR (<2.5) than observable in patient with normal TTE-CFR 
(>2.5) and during the follow-up, the highest TTE-CFR values are related to the functional 
recovery, well indicated by the WMSI43. The CFR assessment does not help in differentiating 
microcirculatory dysfunction and epiacrdial stenoses when both problems are present, but 
in one case: in patients who underwent heart transplantation. TTE-CFR provides useful 
information on microcirculation and on the Cardiac Allograft Vasculopathy (CAV), a 
condition implying both epicardial coronary and microvasculation disease44. Angiograpghy 
usually underestimate the seriousness of the problem44 and the Intravascular Ultrasound 
(IVUS) is the (invasive) gold standard examination to perform45. This is a  micro- and 
macrovascular kind of damage and a reduced TTE-CFR allows a diagnosis of CAV if <2.7 
(sensitivity 87%, specificity 82%)46. 
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